心力衰竭患者睡眠呼吸障碍的研究进展_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

LIU Jinghui ¹ , LIANG Shuang ¹ , WANG Jiachi ¹ ,  LIU Fangli ^1,2

1. ;
2. ;

Corresponding author：

LIU Fangli, Email: liufangli1229@126.com

Keywords：

DOI：

10.7507/1671-6205.202403051

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： LIU Jinghui, LIANG Shuang, WANG Jiachi, LIU Fangli. 心力衰竭患者睡眠呼吸障碍的研究进展. Chinese Journal of Respiratory and Critical Care Medicine, 2025, 24(1): 58-63. doi: 10.7507/1671-6205.202403051 Copy

1.	GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 2018, 392(10159): 1789-1858.
2.	Wang H, Chai K, Du M, et al. Prevalence and incidence of heart failure among urban patients in China: a national population-based analysis. Circ Heart Fail, 2021, 14(10): e008406.
3.	Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics-2023 update: a report from the American heart association. Circulation, 2023, 147(8): e93-e621.
4.	Danielsen R, Thorgeirsson G, Einarsson H, et al. Prevalence of heart failure in the elderly and future projections: the AGES-Reykjavík study. Scand Cardiovasc J, 2017, 51(4): 183-189.
5.	Sateia MJ. International classification of sleep disorders-third edition: highlights and modifications. Chest, 2014, 146(5): 1387-1394.
6.	Ardelean CL, Lighezan DF, Pescariu S, et al. Sleep apnea syndrome and heart failure—mechanisms and consequences. Pneumologia, 2019, 68(2): 61-67.
7.	Yeghiazarians Y, Jneid H, Tietjens JR, et al. Obstructive sleep apnea and cardiovascular disease: a scientific statement from the American Heart Association. Circulation, 2021, 144(3): e56-e67.
8.	Naughton MT, Kee K. Sleep apnea in heart failure: to treat or not to treat?. Respirology, 2017, 22(2): 217-229.
9.	陈宇洁, 韩芳, 钱小顺, 等. 老年睡眠呼吸暂停综合征诊断评估专家共识. 中国全科医学, 2022, 25(11): 1283-1293.
10.	Omran H, Bitter T, Horstkotte D, et al. Characteristics and circadian distribution of cardiac arrhythmias in patients with heart failure and sleep-disordered breathing. Clin Res Cardiol, 2018, 107(10): 965-974.
11.	Dharia SM, Brown LK. Epidemiology of sleep-disordered breathing and heart failure: what drives what. Curr Heart Fail Rep, 2017, 14(5): 351-364.
12.	Wang T, Yu FC, Wei Q, et al. Sleep-disordered breathing in heart failure patients with different etiologies. Clin Cardiol, 2022, 45(7): 778-785.
13.	Arzt M, Oldenburg O, Graml A, et al. Prevalence and predictors of sleep-disordered breathing in chronic heart failure: the SchlaHF-XT registry. ESC Heart Fail, 2022, 9(6): 4100-4111.
14.	Arzt M, Woehrle H, Oldenburg O, et al. Prevalence and predictors of sleep-disordered breathing in patients with stable chronic heart failure: the SchlaHF registry. JACC Heart Fail, 2016, 4(2): 116-125.
15.	Lo S, Mbanze I, Orr JE, et al. The prevalence of sleep-disordered breathing and associated risk factors in patients with decompensated congestive heart failure in Mozambique. J Clin Sleep Med, 2023, 19(6): 1103-1110.
16.	Tamisier R, Bocquillon V, Treptow E, et al. Prevalence and factors contributing to daytime and nocturnal hypoxemia in chronic heart failure patients. Respiration, 2019, 97(3): 213-222.
17.	Huang B, Huang Y, Zhai M, et al. Prevalence, clinical characteristics, and predictors of sleep disordered breathing in hospitalized heart failure patients. Clin Cardiol, 2022, 45(12): 1311-1318.
18.	Pearse SG, Cowie MR. Sleep-disordered breathing in heart failure. Eur J Heart Fail, 2016, 18(4): 353-361.
19.	Javaheri S, Badr MS. Central sleep apnea: pathophysiologic classification. Sleep, 2023, 46(3): zsac113.
20.	张慧, 吕慧霞. 阻塞性睡眠呼吸暂停在心衰进展中的作用机制及其治疗研究进展. 山东大学耳鼻喉眼学报, 2023, 37(6): 33-40.
21.	Parati G, Lombardi C, Castagna F, et al. Heart failure and sleep disorders. Nat Rev Cardiol, 2016, 13(7): 389-403.
22.	Taranto ML, Floras JS, Picton P, et al. Relationship of heart rate variability to sleepiness in patients with obstructive sleep apnea with and without heart failure. J Clin Sleep Med, 2014, 10(3): 271-276.
23.	Ott SR, Korostovtseva L, Schmidt M, et al. Sleep-disordered breathing: clinical features, pathophysiology and diagnosis. Swiss Med Wkly, 2020, 147: w14436.
24.	Sands SA, Owens RL. Congestive heart failure and central sleep apnea. Sleep Med Clin, 2016, 11(1): 127-142.
25.	Javaheri S, Brown LK, Abraham WT, et al. Apneas of heart failure and phenotype-guided treatments: part one: OSA. Chest, 2020, 157(2): 394-402.
26.	朱鹏力, 赵信科, 蒋虎刚, 等. 心力衰竭合并中枢型睡眠呼吸暂停综合征的治疗方案及机制研究新进展. 心血管病学进展, 2021, 42(1): 59-63.
27.	Zhang K, Ma Z, Song C, et al. Role of ion channels in chronic intermittent hypoxia-induced atrial remodeling in rats. Life Sci, 2020, 254: 117797.
28.	Netzer NC, Stoohs RA, Netzer CM, et al. Using the Berlin questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med, 1999, 131(7): 485-491.
29.	Saengsuwan J, Ungtrakul N, Saengsuwan J, et al. Preliminary validity and reliability of a Thai Berlin questionnaire in stroke patients. BMC Res Notes, 2014, 7: 348.
30.	Lauritzen E, Kørvel HA, Homøe P. The Danish translation and validation of the Berlin questionnaire for sleep apnoea. Dan Med J, 2018, 65(9): A5502.
31.	Senaratna CV, Perret JL, Matheson MC, et al. Validity of the Berlin questionnaire in detecting obstructive sleep apnea: a systematic review and meta-analysis. Sleep Med Rev, 2017, 36: 116-124.
32.	Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep, 1991, 14(6): 540-545.
33.	Johns MW. Reliability and factor analysis of the Epworth sleepiness scale. Sleep, 1992, 15(4): 376-381.
34.	彭莉莉, 李进让, 孙建军, 等. Epworth嗜睡量表简体中文版信度和效度评价. 中华耳鼻咽喉头颈外科杂志, 2011, 46(1): 6.
35.	Lok R, Zeitzer JM. Physiological correlates of the Epworth sleepiness scale reveal different dimensions of daytime sleepiness. Sleep Adv, 2021, 2(1): zpab008.
36.	Chung F, Yegneswaran B, Liao P, et al. STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology, 2008, 108(5): 812-821.
37.	Chiu HY, Chen PY, Chuang LP, et al. Diagnostic accuracy of the Berlin questionnaire, STOP-BANG, STOP, and Epworth sleepiness scale in detecting obstructive sleep apnea: a bivariate meta-analysis. Sleep Med Rev, 2017, 36: 57-70.
38.	Marti SH, Hirotsu C, Marques VP, et al. The NoSAS score for screening of sleep-disordered breathing: a derivation and validation study. Lancet Respir Med, 2016, 4(9): 742-748.
39.	Hong C, Chen R, Qing S, et al. Validation of the NoSAS score for the screening of sleep-disordered breathing: a hospital-based retrospective study in China. J Clin Sleep Med, 2018, 14(2): 191-197.
40.	Herschmann S, Berger M, Haba RJ, et al. Comparison of NoSAS score with Berlin and STOP-BANG scores for sleep apnea detection in a clinical sample. Sleep Med, 2021, 79: 113-116.
41.	Koseoglu HI, Pazarli AC, Kanbay A, et al. NoSAS score predicts cardiovascular disease in patients with obstructive sleep apnea. Sleep Breath, 2024, 28(1): 87-93.
42.	Rundo JV, Downey R 3rd. Polysomnography. Handb Clin Neurol, 2019, 160: 381-392.
43.	Zhang X, Song Z, Ye J, et al. Polysomnographic and neuropsychological characteristics of rapid eye movement sleep behavior disorder patients. Brain Behav, 2019, 9(3): e01220.
44.	Hertenstein E, Gabryelska A, Spiegelhalder K, et al. Reference data for polysomnography-measured and subjective sleep in healthy adults. J Clin Sleep Med, 2018, 14(4): 523-532.
45.	Kreutz C, Müller J, Schmidt ME, et al. Comparison of subjectively and objectively assessed sleep problems in breast cancer patients starting neoadjuvant chemotherapy. Support Care Cancer, 2021, 29(2): 1015-1023.
46.	杨璇, 乔雨晨, 赵洁, 等. 认知障碍患者睡眠障碍评估工具的应用进展. 中华护理杂志, 2020, 55(12): 1884-1889.
47.	Cabanel N, Speier C, Müller MJ, et al. Actigraphic, but not subjective, sleep measures are associatedwith cognitive impairment in memory clinic patients. Psychogeriatrics, 2020, 20(2): 133-139.
48.	Patterson MR, Nunes AAS, Gerstel D, et al. 40 years of actigraphy in sleep medicine and current state of the art algorithms. NPJ Digit Med, 2023, 6(1): 51.
49.	Smith MT, Mccrae CS, Cheung J, et al. Use of actigraphy for the evaluation of sleep disorders and circadian rhythm sleep-wake disorders: an American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med, 2018, 14(7): 1231-1237.
50.	Hernandez AV, Jeon A, Denegri GJ, et al. Use of adaptive servo ventilation therapy as treatment of sleep-disordered breathing and heart failure: a systematic review and meta-analysis. Sleep Breath, 2020, 24(1): 49-63.
51.	Alemohammad ZB, Sadeghniiat HK, Fazlipanah MMP, et al. The effects of CPAP therapy on metabolic profile and subjective sleep parameters in patients with OSA: a prospective trial study. Sleep Sci, 2022, 15(2): 196-200.
52.	张文珺, 刘永铭. 睡眠呼吸障碍对射血分数保留性心力衰竭影响及治疗的研究进展. 中国临床研究, 2022, 35(04): 552-555.
53.	Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol, 2022, 79(17): e263-e421.
54.	Han YC, Shen ZJ, Zhang SY, et al. Efficacy of adaptive servo-ventilation and continuous positive airway pressure treatment in chronic heart failure with sleep-disordered breathing: a systematic review and meta-analysis. Heart Fail Rev, 2021, 26(3): 521-529.
55.	Ponce S, Pastor E, Orosa B, et al. The role of CPAP treatment in elderly patients with moderate obstructive sleep apnoea: a multicentre randomised controlled trial. Eur Respir J, 2019, 54(2): 1900518.
56.	Randerath W, Deleanu O, Schiza S, et al. Central sleep apnoea and periodic breathing in heart failure: prognostic significance and treatment options. Eur Respir Rev, 2019, 28(153): 190084.
57.	郭舒雯, 许鑫. 适应性支持通气治疗慢性心力衰竭合并睡眠呼吸障碍疾病42例. 心理月刊, 2019, 14(13): 179.
58.	Wang J, Covassin N, Dai T, et al. Therapeutic value of treating central sleep apnea by adaptive servo-ventilation in patients with heart failure: a systematic review and meta-analysis. Heart Lung, 2021, 50(2): 344-351.
59.	朱鹏力, 赵信科, 蒋虎刚, 等. 膈神经刺激在中枢性和阻塞性睡眠呼吸暂停综合征治疗中的应用研究进展. 中国实用内科杂志, 2021, 41(12): 1069-1072+1077.
60.	Costanzo MR, Ponikowski P, Coats A, et al. Phrenic nerve stimulation to treat patients with central sleep apnoea and heart failure. Eur J Heart Fail, 2018, 20(12): 1746-1754.
61.	Fudim M, Spector AR, Costanzo MR, et al. Phrenic nerve stimulation for the treatment of central sleep apnea: a pooled cohort analysis. J Clin Sleep Med, 2019, 15(12): 1747-1755.
62.	Fox H, Oldenburg O, Javaheri S, et al. Long-term efficacy and safety of phrenic nerve stimulation for the treatment of central sleep apnea. Sleep, 2019, 42(11): zsz158.
63.	Abraham WT, Jagielski D, Oldenburg O, et al. Phrenic nerve stimulation for the treatment of central sleep apnea. JACC Heart Fail, 2015, 3(5): 360-369.
64.	黄晓芸, 庄振中, 江意春, 等. 体外膈肌起搏器在慢性心衰患者治疗中的作用. 中国医学物理学杂志, 2017, 34(01): 84-88.
65.	Randerath W, Verbraecken J, Andreas S, et al. Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep. Eur Respir J, 2017, 49(1): 1600959.
66.	Yoshihisa A, Takeishi Y. Heart failure and sleep disordered breathing. Fukushima J Med Sci, 2017, 63(2): 32-38.
67.	席紫明. 茶碱对慢性心力衰竭合并睡眠呼吸障碍患者睡眠状态的影响观察. 世界睡眠医学杂志, 2018, 5(7): 843-845.
68.	李胜男, 谢亮, 童嘉毅. 阻塞性睡眠呼吸暂停的药物治疗研究进展. 心血管病学进展, 2023, 44(8): 748-751,756.
69.	Eskandari D, Zou D, Grote L, et al. Acetazolamide reduces blood pressure and sleep-disordered breathing in patients with hypertension and obstructive sleep apnea: a randomized controlled trial. J Clin Sleep Med, 2018, 14(3): 309-317.
70.	Nakao YM, Ueshima K, Yasuno S, et al. Effects of nocturnal oxygen therapy in patients with chronic heart failure and central sleep apnea: CHF-HOT study. Heart Vessels, 2016, 31(2): 165-172.

1. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 2018, 392(10159): 1789-1858.
2. Wang H, Chai K, Du M, et al. Prevalence and incidence of heart failure among urban patients in China: a national population-based analysis. Circ Heart Fail, 2021, 14(10): e008406.
3. Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics-2023 update: a report from the American heart association. Circulation, 2023, 147(8): e93-e621.
4. Danielsen R, Thorgeirsson G, Einarsson H, et al. Prevalence of heart failure in the elderly and future projections: the AGES-Reykjavík study. Scand Cardiovasc J, 2017, 51(4): 183-189.
5. Sateia MJ. International classification of sleep disorders-third edition: highlights and modifications. Chest, 2014, 146(5): 1387-1394.
6. Ardelean CL, Lighezan DF, Pescariu S, et al. Sleep apnea syndrome and heart failure—mechanisms and consequences. Pneumologia, 2019, 68(2): 61-67.
7. Yeghiazarians Y, Jneid H, Tietjens JR, et al. Obstructive sleep apnea and cardiovascular disease: a scientific statement from the American Heart Association. Circulation, 2021, 144(3): e56-e67.
8. Naughton MT, Kee K. Sleep apnea in heart failure: to treat or not to treat?. Respirology, 2017, 22(2): 217-229.
9. 陈宇洁, 韩芳, 钱小顺, 等. 老年睡眠呼吸暂停综合征诊断评估专家共识. 中国全科医学, 2022, 25(11): 1283-1293.
10. Omran H, Bitter T, Horstkotte D, et al. Characteristics and circadian distribution of cardiac arrhythmias in patients with heart failure and sleep-disordered breathing. Clin Res Cardiol, 2018, 107(10): 965-974.
11. Dharia SM, Brown LK. Epidemiology of sleep-disordered breathing and heart failure: what drives what. Curr Heart Fail Rep, 2017, 14(5): 351-364.
12. Wang T, Yu FC, Wei Q, et al. Sleep-disordered breathing in heart failure patients with different etiologies. Clin Cardiol, 2022, 45(7): 778-785.
13. Arzt M, Oldenburg O, Graml A, et al. Prevalence and predictors of sleep-disordered breathing in chronic heart failure: the SchlaHF-XT registry. ESC Heart Fail, 2022, 9(6): 4100-4111.
14. Arzt M, Woehrle H, Oldenburg O, et al. Prevalence and predictors of sleep-disordered breathing in patients with stable chronic heart failure: the SchlaHF registry. JACC Heart Fail, 2016, 4(2): 116-125.
15. Lo S, Mbanze I, Orr JE, et al. The prevalence of sleep-disordered breathing and associated risk factors in patients with decompensated congestive heart failure in Mozambique. J Clin Sleep Med, 2023, 19(6): 1103-1110.
16. Tamisier R, Bocquillon V, Treptow E, et al. Prevalence and factors contributing to daytime and nocturnal hypoxemia in chronic heart failure patients. Respiration, 2019, 97(3): 213-222.
17. Huang B, Huang Y, Zhai M, et al. Prevalence, clinical characteristics, and predictors of sleep disordered breathing in hospitalized heart failure patients. Clin Cardiol, 2022, 45(12): 1311-1318.
18. Pearse SG, Cowie MR. Sleep-disordered breathing in heart failure. Eur J Heart Fail, 2016, 18(4): 353-361.
19. Javaheri S, Badr MS. Central sleep apnea: pathophysiologic classification. Sleep, 2023, 46(3): zsac113.
20. 张慧, 吕慧霞. 阻塞性睡眠呼吸暂停在心衰进展中的作用机制及其治疗研究进展. 山东大学耳鼻喉眼学报, 2023, 37(6): 33-40.
21. Parati G, Lombardi C, Castagna F, et al. Heart failure and sleep disorders. Nat Rev Cardiol, 2016, 13(7): 389-403.
22. Taranto ML, Floras JS, Picton P, et al. Relationship of heart rate variability to sleepiness in patients with obstructive sleep apnea with and without heart failure. J Clin Sleep Med, 2014, 10(3): 271-276.
23. Ott SR, Korostovtseva L, Schmidt M, et al. Sleep-disordered breathing: clinical features, pathophysiology and diagnosis. Swiss Med Wkly, 2020, 147: w14436.
24. Sands SA, Owens RL. Congestive heart failure and central sleep apnea. Sleep Med Clin, 2016, 11(1): 127-142.
25. Javaheri S, Brown LK, Abraham WT, et al. Apneas of heart failure and phenotype-guided treatments: part one: OSA. Chest, 2020, 157(2): 394-402.
26. 朱鹏力, 赵信科, 蒋虎刚, 等. 心力衰竭合并中枢型睡眠呼吸暂停综合征的治疗方案及机制研究新进展. 心血管病学进展, 2021, 42(1): 59-63.
27. Zhang K, Ma Z, Song C, et al. Role of ion channels in chronic intermittent hypoxia-induced atrial remodeling in rats. Life Sci, 2020, 254: 117797.
28. Netzer NC, Stoohs RA, Netzer CM, et al. Using the Berlin questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med, 1999, 131(7): 485-491.
29. Saengsuwan J, Ungtrakul N, Saengsuwan J, et al. Preliminary validity and reliability of a Thai Berlin questionnaire in stroke patients. BMC Res Notes, 2014, 7: 348.
30. Lauritzen E, Kørvel HA, Homøe P. The Danish translation and validation of the Berlin questionnaire for sleep apnoea. Dan Med J, 2018, 65(9): A5502.
31. Senaratna CV, Perret JL, Matheson MC, et al. Validity of the Berlin questionnaire in detecting obstructive sleep apnea: a systematic review and meta-analysis. Sleep Med Rev, 2017, 36: 116-124.
32. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep, 1991, 14(6): 540-545.
33. Johns MW. Reliability and factor analysis of the Epworth sleepiness scale. Sleep, 1992, 15(4): 376-381.
34. 彭莉莉, 李进让, 孙建军, 等. Epworth嗜睡量表简体中文版信度和效度评价. 中华耳鼻咽喉头颈外科杂志, 2011, 46(1): 6.
35. Lok R, Zeitzer JM. Physiological correlates of the Epworth sleepiness scale reveal different dimensions of daytime sleepiness. Sleep Adv, 2021, 2(1): zpab008.
36. Chung F, Yegneswaran B, Liao P, et al. STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology, 2008, 108(5): 812-821.
37. Chiu HY, Chen PY, Chuang LP, et al. Diagnostic accuracy of the Berlin questionnaire, STOP-BANG, STOP, and Epworth sleepiness scale in detecting obstructive sleep apnea: a bivariate meta-analysis. Sleep Med Rev, 2017, 36: 57-70.
38. Marti SH, Hirotsu C, Marques VP, et al. The NoSAS score for screening of sleep-disordered breathing: a derivation and validation study. Lancet Respir Med, 2016, 4(9): 742-748.
39. Hong C, Chen R, Qing S, et al. Validation of the NoSAS score for the screening of sleep-disordered breathing: a hospital-based retrospective study in China. J Clin Sleep Med, 2018, 14(2): 191-197.
40. Herschmann S, Berger M, Haba RJ, et al. Comparison of NoSAS score with Berlin and STOP-BANG scores for sleep apnea detection in a clinical sample. Sleep Med, 2021, 79: 113-116.
41. Koseoglu HI, Pazarli AC, Kanbay A, et al. NoSAS score predicts cardiovascular disease in patients with obstructive sleep apnea. Sleep Breath, 2024, 28(1): 87-93.
42. Rundo JV, Downey R 3rd. Polysomnography. Handb Clin Neurol, 2019, 160: 381-392.
43. Zhang X, Song Z, Ye J, et al. Polysomnographic and neuropsychological characteristics of rapid eye movement sleep behavior disorder patients. Brain Behav, 2019, 9(3): e01220.
44. Hertenstein E, Gabryelska A, Spiegelhalder K, et al. Reference data for polysomnography-measured and subjective sleep in healthy adults. J Clin Sleep Med, 2018, 14(4): 523-532.
45. Kreutz C, Müller J, Schmidt ME, et al. Comparison of subjectively and objectively assessed sleep problems in breast cancer patients starting neoadjuvant chemotherapy. Support Care Cancer, 2021, 29(2): 1015-1023.
46. 杨璇, 乔雨晨, 赵洁, 等. 认知障碍患者睡眠障碍评估工具的应用进展. 中华护理杂志, 2020, 55(12): 1884-1889.
47. Cabanel N, Speier C, Müller MJ, et al. Actigraphic, but not subjective, sleep measures are associatedwith cognitive impairment in memory clinic patients. Psychogeriatrics, 2020, 20(2): 133-139.
48. Patterson MR, Nunes AAS, Gerstel D, et al. 40 years of actigraphy in sleep medicine and current state of the art algorithms. NPJ Digit Med, 2023, 6(1): 51.
49. Smith MT, Mccrae CS, Cheung J, et al. Use of actigraphy for the evaluation of sleep disorders and circadian rhythm sleep-wake disorders: an American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med, 2018, 14(7): 1231-1237.
50. Hernandez AV, Jeon A, Denegri GJ, et al. Use of adaptive servo ventilation therapy as treatment of sleep-disordered breathing and heart failure: a systematic review and meta-analysis. Sleep Breath, 2020, 24(1): 49-63.
51. Alemohammad ZB, Sadeghniiat HK, Fazlipanah MMP, et al. The effects of CPAP therapy on metabolic profile and subjective sleep parameters in patients with OSA: a prospective trial study. Sleep Sci, 2022, 15(2): 196-200.
52. 张文珺, 刘永铭. 睡眠呼吸障碍对射血分数保留性心力衰竭影响及治疗的研究进展. 中国临床研究, 2022, 35(04): 552-555.
53. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol, 2022, 79(17): e263-e421.
54. Han YC, Shen ZJ, Zhang SY, et al. Efficacy of adaptive servo-ventilation and continuous positive airway pressure treatment in chronic heart failure with sleep-disordered breathing: a systematic review and meta-analysis. Heart Fail Rev, 2021, 26(3): 521-529.
55. Ponce S, Pastor E, Orosa B, et al. The role of CPAP treatment in elderly patients with moderate obstructive sleep apnoea: a multicentre randomised controlled trial. Eur Respir J, 2019, 54(2): 1900518.
56. Randerath W, Deleanu O, Schiza S, et al. Central sleep apnoea and periodic breathing in heart failure: prognostic significance and treatment options. Eur Respir Rev, 2019, 28(153): 190084.
57. 郭舒雯, 许鑫. 适应性支持通气治疗慢性心力衰竭合并睡眠呼吸障碍疾病42例. 心理月刊, 2019, 14(13): 179.
58. Wang J, Covassin N, Dai T, et al. Therapeutic value of treating central sleep apnea by adaptive servo-ventilation in patients with heart failure: a systematic review and meta-analysis. Heart Lung, 2021, 50(2): 344-351.
59. 朱鹏力, 赵信科, 蒋虎刚, 等. 膈神经刺激在中枢性和阻塞性睡眠呼吸暂停综合征治疗中的应用研究进展. 中国实用内科杂志, 2021, 41(12): 1069-1072+1077.
60. Costanzo MR, Ponikowski P, Coats A, et al. Phrenic nerve stimulation to treat patients with central sleep apnoea and heart failure. Eur J Heart Fail, 2018, 20(12): 1746-1754.
61. Fudim M, Spector AR, Costanzo MR, et al. Phrenic nerve stimulation for the treatment of central sleep apnea: a pooled cohort analysis. J Clin Sleep Med, 2019, 15(12): 1747-1755.
62. Fox H, Oldenburg O, Javaheri S, et al. Long-term efficacy and safety of phrenic nerve stimulation for the treatment of central sleep apnea. Sleep, 2019, 42(11): zsz158.
63. Abraham WT, Jagielski D, Oldenburg O, et al. Phrenic nerve stimulation for the treatment of central sleep apnea. JACC Heart Fail, 2015, 3(5): 360-369.
64. 黄晓芸, 庄振中, 江意春, 等. 体外膈肌起搏器在慢性心衰患者治疗中的作用. 中国医学物理学杂志, 2017, 34(01): 84-88.
65. Randerath W, Verbraecken J, Andreas S, et al. Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep. Eur Respir J, 2017, 49(1): 1600959.
66. Yoshihisa A, Takeishi Y. Heart failure and sleep disordered breathing. Fukushima J Med Sci, 2017, 63(2): 32-38.
67. 席紫明. 茶碱对慢性心力衰竭合并睡眠呼吸障碍患者睡眠状态的影响观察. 世界睡眠医学杂志, 2018, 5(7): 843-845.
68. 李胜男, 谢亮, 童嘉毅. 阻塞性睡眠呼吸暂停的药物治疗研究进展. 心血管病学进展, 2023, 44(8): 748-751,756.
69. Eskandari D, Zou D, Grote L, et al. Acetazolamide reduces blood pressure and sleep-disordered breathing in patients with hypertension and obstructive sleep apnea: a randomized controlled trial. J Clin Sleep Med, 2018, 14(3): 309-317.
70. Nakao YM, Ueshima K, Yasuno S, et al. Effects of nocturnal oxygen therapy in patients with chronic heart failure and central sleep apnea: CHF-HOT study. Heart Vessels, 2016, 31(2): 165-172.

Previous Article
体外膜氧合成功救治惠普尔养障体重症肺炎并多器官功能障碍综合征一例
Next Article
阻塞性睡眠呼吸暂停损害心脏的分子机制研究进展

Chinese Journal of Respiratory and Critical Care Medicine

心力衰竭患者睡眠呼吸障碍的研究进展

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content